Board changes at PuriCore

Published: 23-Jun-2014

Charles Spicer appointed Non-Executive Chairman


PuriCore, a global company focused on safe and effective protection against the spread of infectious pathogens, has announced that Charles Spicer, Non-Executive Director, has been appointed Non-Executive Chairman with immediate effect. Michael Ashton will continue to serve as Executive Director and Chief Executive Officer.

  

'This is an exciting phase for PuriCore as we embark upon a strategic review of our businesses following the sale of the Endoscopy division. I look forward to continuing to work with Charles and the rest of the Board to advance shareholder value,' said Ashton.

  • Companies:
  • Cantel (UK)
See more

You may also like

Infection Control

PuriCore to seek admission to AIM

Read more
Board proposes to cancel the listing of the company’s Ordinary Shares on the premium segment of the Official List and their trading on the Main Market

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Steritas and argenx join forces to advance steroid-sparing therapeutic development With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Infection Control

PuriCore to seek admission to AIM

Board proposes to cancel the listing of the company’s Ordinary Shares on the premium segment of the Official List and their trading on the Main Market
Cleaning

PuriCore granted two US patents

Significantly strengthens the company’s product portfolio
Manufacturing

Leybold launches Duradry vacuum pump for harsh processes

Advanced technology designed for reliability and efficiency
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Digital

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient
Manufacturing

Anton Paar expands Litesizer DIA Series with new models

Introducing affordable and advanced solutions for particle analysis
Subscribe now